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LETTERS TO THE EDITOR
Anemia and Energy Depletion
The article by Mozaffarian et al. (1) exposes an important principle
in cardiovascular physiology that is often overlooked. A prerequi-
site for efficient energy transfer in living organisms is the interac-
tion of a series of moiety-conserved cycles (2). Cycles improve
efficiency and offer an evolutionary advantage (3). Examples of
moiety-conserved cycles are the circulation, the Krebs cycle in the
mitochondria, and the cross-bridge cycling in the sarcomeres.
Anemia deprives the circulation of its most important moiety—red
blood cells. From a metabolic perspective, we would like to
propose that anemia deprives the body of its primary source of
energy when the heart fails to compensate for the decreased
amount of red blood cells. Anemia may also contribute to
pathologic remodeling of the ventricle in heart failure. Experimen-
tal models of anemia have been shown to induce a pattern of
metabolic gene expression observed in patients with heart failure
(4). This contribution to the progression of heart failure by anemia
further impairs the heart’s ability to compensate for the decline in
red blood cells.
We offer these explanations for the findings of the study by
Mozaffarian et al. (1) and also for the recently reported beneficial
effects of blood transfusion in elderly patients with acute myocar-
dial infarctions (5).
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REPLY
Drs. Taegtmeyer and Sharma reiterate an important plausible
biologic mechanism for the observed association between anemia
and higher mortality in severe heart failure. As we also hypothe-
sized (1), diminished oxygen-carrying capacity of anemic blood
may necessitate higher cardiac output to meet systemic metabolic
requirements; the concomitant increased neurohormonal activa-
tion may cause heart failure progression, producing a progressive
cycle of metabolic–hemodynamic compromise. This hypothesis is
supported by the inverse association between anemia and death
due to progressive heart failure, rather than due to sudden death or
other deaths (1). However, there are other potential explanations
for the observed association between anemia and mortality in heart
failure (1). We look forward to testing of this plausible metabolic–
hemodynamic hypothesis in ongoing experimental and clinical
trials.
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